搜索筛选:
搜索耗时4.5458秒,为你在为你在102,285,761篇论文里面共找到 16 篇相符的论文内容
类      型:
[会议论文] 作者:Xiaokun Shen, 来源:第11届全军呼吸内科专业委员会年会 年份:2011
[会议论文] 作者:Xiaokun shen, 来源:中华医学会第十一次全国呼吸病学术会议 年份:2010
[会议论文] 作者:Kan Ding,Xiaokun Shen,Songshan Jiang, 来源:第一届亚洲小核酸会议暨第二届中国小核酸技术与应用学术会议 年份:2009
[会议论文] 作者:Xiaokun Shen,Songshan Jiang,Kan Ding, 来源:第一届亚洲小核酸会议暨第二届中国小核酸技术与应用学术会议 年份:2009
[会议论文] 作者:Ying Wang,Hong Qiu,Xiaokun Shen,Jianping Fang,Kan Ding, 来源:The 3rd Asian Communications of Glycobiology and Glycotechno 年份:2011
[会议论文] 作者:Tangfeng Lv,Xiaohui Miao,Yanling Lv,Ping Zhan,Xiaokun Shen,Yong Song, 来源:中国抗癌学会肺癌专业委员会第十二届全国肺癌学术大会 年份:2011
Background Lysine specific demethylase 1 (LSD1)has been identified and biochemically characterized in epigenetics, but the pathological roles of its dysfunction in lung cancer have not been well under...
[会议论文] 作者:Xiaokun Shen,Chuang Guo,Yanyan Liu,Jiabin Li,Rui Sun,Zhigang Tian,Binqing Fu,Haiming Wei, 来源:The 1st NI-CMI Joint Conference(第一届CMI-NI免疫学国际研讨会) 年份:2015
[会议论文] 作者:Xiaokun Shen,Yanyan Liu,Chuang Guo,Binqing Fu,Rui Sun,Jiabin Li,Zhigang Tian,Haiming Wei, 来源:The 1st NI-CMI Joint Conference(第一届CMI-NI免疫学国际研讨会) 年份:2015
There is a pressing need to improve therapeutic options for HBV, which is still estimated to cause more than a million deaths a year, from liver cirrhosis and hepatocellular carcinoma.Pegylated interf...
[会议论文] 作者:Xiaokun Shen,Haiming Wei,Chuang Guo,Dongyao Wang,Rui Sun,Binqing Fu,Yanyan Liu,Jiabin Li,Zhigang Tian, 来源:中国免疫学会第十届全国免疫学学术大会 年份:2015
  Background: More than 60% of patients infected with hepatitis B virus (HBV) regarded as NR have a diminished HBV virologic response to standard interferon (...
[会议论文] 作者:Xiaokun Shen,Yanyan Liu,Chuang Guo,Binqing Fu,Ying Ye,Rui Sun,Jiabin Li,Zhigang Tian,Haiming Wei, 来源:中国免疫学会第十届全国免疫学学术大会 年份:2015
Approximately 400 million people are chronic HBV surface antigen carriers.There is a pressing need to improve therapeutic options for chronic hepatitis B.Pegylated interferon alpha (Peg-IFN-α) achieve...
[会议论文] 作者:Dongyao Wang,Binqing Fu,Xiaokun Shen,Yanyan Liu,Chuang Guo,Rui Sun,Jiabin Li,Zhigang Tian,Haiming Wei, 来源:中国免疫学会第十届全国免疫学学术大会 年份:2015
Background: More than 60% of patients infected with hepatitis B virus (HBV) regarded as NR have a diminished HBV virologic response to standard interferon (IFN)-based therapies....
[会议论文] 作者:Xiaokun Shen,Bojian Xie,Zhaosheng Ma,Feilin Cao,Xinxin Fan,Liang Cao,Beibei Chen,Huifang Lv,Xiaobing, 来源:第十二届国际胃癌学术会议 年份:2017
Objective: The epithelial-mesenchymal transition(EMT)contributes to cancer progression,and aberrant gastric EMT activation could promote cancer cell stemness,initiation,invasion,and metastasis....
[会议论文] 作者:Wenting Li,Xiaokun Shen,Binqing Fu,Chuang Guo,Yanyan Liu,Ying Ye,Rui Sun,Jiabin Li,Zhigang Tian,Haiming, 来源:中国免疫学会第十届全国免疫学学术大会 年份:2015
Natural killer (NK) cells play a key role in host defense against viral infection through their surface activating or inhibitory receptors....
[会议论文] 作者:Xiaokun Shen,Chuang Guo,Yongyan Chen,Fang Ni,Rui Sun,Haiming Wei,Binqing Fu,Yanyan Liu,Ying Ye,Jiabin, 来源:The 1st NI-CMI Joint Conference(第一届CMI-NI免疫学国际研讨会) 年份:2015
[会议论文] 作者:Chuang Guo,Xiaokun Shen,Binqing Fu,Yanyan Liu,Yongyan Chen,Fang Ni,Ying Ye,Rui Sun,Jiabin Li,Zhigang, 来源:The 1st NI-CMI Joint Conference(第一届CMI-NI免疫学国际研讨会) 年份:2015
Chronic hepatitis B infection is a serious and prevalent health concern worldwide, and the development of effective drugs and strategies to combat this disease is urgently needed.Currently, pegylated...
[期刊论文] 作者:Shenyang Wu,Shuya Li,Nian Wu,Tingzhong Tian,Xiaolong Feng,Hantao Shu,Peng Lang,Jingxin Li,Fengcai Zhu,Xiaokun Shen, 来源:蛋白质与细胞 年份:2021
Dear EditorrnTo date,tens of millions of people have been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),causing the outbreak of the respiratory disease named the coronavirus disease 2019 (COVID-19).As a newly em......
相关搜索: